Articles & Video
Life Sciences Accounting & Reporting Congress Executive Summary
This executive summary of the Life Science Accounting & Reporting Congress, looks at three key sessions offering insights and best practices on some of the most important issues facing accounting leaders in life sciences companies.
Revolutionize and automate life sciences transactions using blockchain - Panel Discussion
Discover how blockchain can revolutionize and automate life sciences transactions - watch a panel discussion of industry experts.
Pulse on Progress Report: Digital transformation within life sciences finance and accounting
Explore the data from the digital transformation within life sciences finance and accounting benchmarking report.
Pharma/Biotech GTN Summit Benchmarking Report 2021
Explore the data from the Pharma/Biotech GTN Summit Benchmarking Report
Escalating GTN reductions puts pressure on sales
We explore how pharmaceutical manufacturers' sales funnels are being clogged by escalating gross-to-net (GTN) reductions.
Life Sciences Survey: COVID-19 Impacts One Year On
Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.
Executive Summary: Key Sessions from Life Sciences Accounting & Reporting Congress
Read the executive summary of some key sessions from the recent Life Sciences Accounting & Reporting Congress.
Diversity, Equity and Inclusion Beyond the Four Walls of an Organization
How have life sciences diversity efforts expanded beyond an organization’s four walls to encompass the entire ecosystem and to include social justice?
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
Blog Post: Impact of Medicare Part D Donut Hole on GTN
View this blog post for an inside look at the impact of Medicare Part D Donut Hole on GTN.